![](/wp-content/uploads/rapidlogo.png)
February 1, 2023
BURLINGTON, Ontario – February 1, 2023 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), has filed its financial results for the first three quarters of the 2023 fiscal year. Now that the Company has completed the filing of its audited financial statements...
![](https://rapid-dose.com/wp-content/uploads/2017/09/RDT_med_logo.png)
January 17, 2023
Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order BURLINGTON, Ontario – January 17, 2023 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, announces that further to its press release...
![](https://rapid-dose.com/wp-content/uploads/2017/09/RDT_med_logo.png)
January 10, 2023
BURLINGTON, Ontario – January 10, 2023 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, announces that further to its press release dated December 20, 2022, the Company and its auditors are continuing to...
![](https://rapid-dose.com/wp-content/uploads/2017/09/RDT_med_logo.png)
December 29, 2022
Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order BURLINGTON, Ontario – December 29, 2022 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, announces that further to its press release...
![](https://rapid-dose.com/wp-content/uploads/2017/09/RDT_med_logo.png)
December 21, 2022
Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order BURLINGTON, Ontario – December 20, 2022 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, announces that further to its press release...
![](https://rapid-dose.com/wp-content/uploads/2017/09/RDT_med_logo.png)
December 12, 2022
Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order BURLINGTON, Ontario – December 12, 2022 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, announces that further to its press release...
![](https://rapid-dose.com/wp-content/uploads/2017/09/RDT_med_logo.png)
November 7, 2022
BURLINGTON, Ontario – November 7, 2022 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, announces that further to its press release dated September 12, 2022, the Company and its auditors are continuing to...
![](https://rapid-dose.com/wp-content/uploads/2017/09/RDT_med_logo.png)
October 24, 2022
BURLINGTON, Ontario – October 24, 2022 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, announces that further to its press release dated September 12, 2022, the Company and its auditors are continuing to...
![](https://rapid-dose.com/wp-content/uploads/2017/09/RDT_med_logo.png)
October 12, 2022
BURLINGTON, Ontario – October 11, 2022 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, announces that further to its press release dated September 12, 2022, the Company and its auditors are continuing to...
![](https://rapid-dose.com/wp-content/uploads/2017/09/RDT_med_logo.png)
September 28, 2022
BURLINGTON, Ontario – September 29, 2022 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, is one of five Canadian companies accepted into this year’s Venture Mentoring Services program offered by the Maryland Tech...